Spoendlin, Julia <br/><br/>
Spironolactone may reduce the risk of incident rosacea.  [electronic resource] 

 -  The Journal of investigative dermatology  Oct 2013 
 - 2480-2483 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2013.186  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Databases, Factual<br/>Diuretics--therapeutic use<br/>Female<br/>Humans<br/>Incidence<br/>Male<br/>Risk Factors<br/>Rosacea--epidemiology<br/>Spironolactone--therapeutic use